Technology Focus: Down to the Last Detail

• by Shannon Simcox, contributing editor

• September 1, 2025

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

• by Andrea Surnit

• May 11, 2026

• 3 min

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.

• by Patricio G. Schlottmann, MD, Patricio G. Schlottmann, MD

• May 14, 2026

• 2 min

GP Insights: <br>Tailoring Astigmatism Correction in Ortho-k</br>

• by John Mark Jackson, OD, MS, FAAO

• May 1, 2026

• 3 min